Higher dose and dose-rate in smaller tumors result in improved tumor control

Cancer Investigation

Volumn 21, Issue 3, 2003, Pages 382-388+x

  Mayer, Astrid ^a   Tsiompanou, E ^a   Flynn, A A ^a   Pedley, R B ^a   Dearling, J ^a   Boden, R ^a   Begent, R H J ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Dose rate; LoVo xenografts; Radioimmunotherapy; Radioluminography

Indexed keywords

ANTIBODY; CARCINOEMBRYONIC ANTIBODY; FLUOROURACIL; FOLINIC ACID; IODINE 131;

ANIMAL MODEL; ARTICLE; CANCER CONTROL; COLON CANCER; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; MICROSCOPY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; RADIOIMMUNOTHERAPY; RADIOSENSITIVITY; TUMOR VOLUME; XENOGRAFT;

ANIMALS; CARCINOEMBRYONIC ANTIGEN; CELL DIVISION; CELL SURVIVAL; COLONIC NEOPLASMS; FEMALE; HUMANS; IODINE RADIOISOTOPES; MICE; MICE, NUDE; RADIOTHERAPY DOSAGE; TIME FACTORS; TRANSPLANTATION, HETEROLOGOUS;

EID: 0042358684     PISSN: 07357907     EISSN: None     Source Type: Journal    
DOI: 10.1081/CNV-120018229     Document Type: Article

References (22)

1. Boyle, P. Some recent developments in the epidemiology of colorectal cancer. In Management of colorectal cancer; Bleiberg, H., Rougier, P., Wilke, H.J., Eds.; Martin Dunitz: London, 1998; 19-34.
2. Moertel, C.G.; Fleming, T.R.; MacDonald, J.S.; Haller, D.G.; Laurie, J.A.; Goodman, P.J.; Ungerleider, J.S.; Emerson, W.A.; Tormey, D.C.; Glick, J.H.; Veeder, M.H.; Mailliard, J.A. Levamisol and fluorouracil for adjuvant therapy of resected colon carcinoma. NEJM 1990, 322, 352-358.
3. Slamon, D.J.; Leyland-Jones, B.; Shak, S.; Fuchs, H.; Paton, V.; Bajamonde, A.; Fleming, T.; Eiermann, W.; Wolter, J.; Pegram, M.; Baselga, J.; Norton, L. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. NEJM 2001, 344 (11), 783-792.
4. Maloney, D.G.; Liles, T.M.; Czerwinski, D.K.; Waldichuk, C.; Rosenberg, J.; Grillo-Lopez, A.; Levy, R. Phase I clinical trial using escalating single-dose infusion of chimeric anti-CD20 monoclonal antibody (IDEC-C2B8) in patients with recurrent B-cell lymphoma. Blood 1994, 84 (8), 2457-2466.
5. Riethmuller, G.; Holz, E.; Schlimok, G.; Schmiegel, W.; Raab, R.; Hoffken, K.; Gruber, R.; Funke, I.; Pichlmaier, H.; Hirche, H.; Buggisch, P.; Witte, J.; Pichlmayr, R. Monoclonal antibody therapy for resected Duke's C colorectal cancer: Seven year outcome of a randomised controled trial. J. Clin. Oncol. 1998, 16, 1788-1794.
6. Punt, C.J.; Nagy, A.; Douillard, J.; Figer, A.; Skovsgaard, T.; Monson, J.; Barone, C.; Jones, D.; Dethling, J.; Colman, J. Edrecolomab (17-1A antibody) alone or in combination with 5-fluorouracil based chemotherapy in the adjuvant treatment of stage III colon cancer: results of a phase III study. ASCO Proc 2001, 20, 123a, 487.
7. Lane, D.M.; Eagle, K.F.; Begent, R.H.; Hope-Stone, L.D.; Green, A.J.; Casey, J.L.; Keep, P.A.; Kelly, A.M.; Ledermann, J.A.; Glaser, M.G.; Hilson, A.J.W. Radioimmunotherapy of metastatic colorectal tumours with iodine 131-labelled antibody to carcinoembryonic antigen: phase I/II study with comparative biodistribution of intact and F(ab')2 antibodies. Br. J. Cancer 1994, 70, 521-525.
8. Behr, T.M.; Liersch, T.; Canelo, R.; Woermann, B.; Hiddemann, W.; Ringe, B.; Becker, H.; Becker, W. Radioimmunotherapy of small volume disease of colorectal cancer: results of a clinical Phase I/II trial. EJC 1999, 35 (Suppl. 5), 93.
9. Pedley, R.B.; Boden, J.; Keep, P.A.; Harwood, P.J.; Green, A.J.; Rogers, G.T. Relationship between tumour size and uptake of radiolabelled anti-CEA in a colon tumour xenograft. Eur. J. Nucl. Med. 1987, 13, 197-202.
10. 131I-labeled monoclonal antibodies. Cancer Res. 1992, 52, 6036-6044.
11. Flynn, A.A.; Green, A.J.; Boxer, G.M.; Casey, J.L.; Pedley, R.B.; Begent, R.H.J. A novel technique, using radioluminography, for the measurement of uniformity of radiolabelled antibody distribution in a colorectal cancer xenograft model. Int. J. Rad. Onc. Biol. Phys. 1999, 43, 183-189.
12. Yokota, T.; Milencic, D.E.; Whitlow, M.; Schlom, J. Rapid tumour penetration of a single chain Fv and comparison with other immunoglobulin forms. Cancer Res. 1992, 52, 1402-1408.
13. Krol, A.; Maresca, J.; Dewhirst, M.W.; Yuan, F. Available volume fraction of macromolecules in the extravascular space of a fibrosarcoma: Implications for drug delivery. Cancer Res. 1999, 59, 4136-4141.
14. Blumenthal, R.D.; Sharkey, R.M.; Natale, A.M.; Kashi, R.; Wong, G.; Goldenberg, D.M. Comparison of equitoxic radioimmunotherapy and chemotherapy in the treatment of human colonic xenografts. Cancer Res. 1994, 54, 142-151.
15. Mayer, A.; Chester, K.A.; Bhatia, J.; Pedley, R.B.; Read, D.A.; Boxer, G.M.; Begent, R.H. Exemplifying guidelines for preparation of recombinant DNA products in phase I trials in cancer: preparation of a genetically engineered anti-CEA single chain Fv antibody. Eur. J. Cancer 1998, 34, 968-976.
16. Laroche, S. Managing very large-scale digital images in microscopy. Microscopy and Analysis 1998, 7, 5-7.
17. Flynn, A.A.; Green, A.J.; Boxer, G.; Pedley, R.B.; Begent, R.H.J. A comparison of image registration techniques for the correlation of radiolabelled antibody distribution with tumour morphology. Phys. Med. Biol. 1999, 44, 151-159.
18. Bardies, M.; Chatal, J.-F. Absorbed doses for internal radiotherapy from 22 beta-emitting radionuclides: beta dosimetry of small spheres. Phys. Med. Biol. 1994, 39, 961-981.
19. Berger, M.J. Distribution of absorbed dose around point sources of electrons and beta particles in water and other media; MIRD pamphlet no.7; Society of Nuclear Medicine: New York, 1971.
20. Jain, R.K. Haemodynamic and transport barriers to the treatment of solid tumours. Int. J. Radiat. Biol. 1991, 60, 85-100.
21. Dvorak, H.F.; Nagy, J.A.; Dvorak, J.T.; Dvorak, A.M. Identification and characterization of the blood vessels of solid tumours that are leaky to circulating macromolecules. Am. J. Pathol. 1988, 133, 95-109.
22. Blumenthal, R.D.; Kashi, R.; Sharkey, R.M.; Goldenberg, D.M. Quantitative and qualitative effects of experimental radioimmunotherapy on tumour vascular permeability. Int. J. Cancer 1995, 61, 557-566.